Versant Venture Capital III, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital III, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital III, L.P.. Versant Venture Capital III, L.P. is a 10% Owner in Trius Therapeutics Inc ($TSRX) and a 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL).
Address: 3000 SAND HILL ROAD BLDG. 4, STE. 210 MENLO PARK 94025 CA
Companies in which Versant Venture Capital III, L.P. is an Insider
OCULAR THERAPEUTIX, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Versant Venture Capital III, L.P.: 10% Owner
Holdings: 13,007 shares
Current Value: $89,878
Latest Transaction: Jun 15 2015
$OCUL Market Capitalization: $171.42M
$OCUL Previous Close: $6.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trius Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Versant Venture Capital III, L.P.: 10% Owner
Holdings: 3,235,839 shares
Latest Transaction: Aug 10 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Versant Venture Capital III, L.P.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 1,878 | 41,316 | 13,007 | 14.9 K to 13 K (-12.62 %) |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 318,122 | 6,998,684 | 2,202,377 | 2.5 M to 2.2 M (-12.62 %) |
| Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 2,506 | 55,132 | 14,885 | 17.4 K to 14.9 K (-14.41 %) |
| Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 424,494 | 9,338,868 | 2,520,499 | 2.9 M to 2.5 M (-14.41 %) |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 4,469,697 | 0 | 0 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 9,090,910 | 0 | 0 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Buy | P | 5.00 | 914,529 | 4,572,645 | 3,235,839 | 2.3 M to 3.2 M (+39.40 %) |
View all Versant Venture Capital III, L.P. insider transactions.